Showing results (71-80 of 208) with videos related to
Sort By:
Pageof 21
BMC Cancer|September 5, 2012
Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell linesSteffen Zopf, Matthias Ocker, Daniel Neureiter, et al.Translational Oncology|April 2, 2013
Endoplasmic reticulum stress plays a pivotal role in cell death mediated by the pan-deacetylase inhibitor panobinostat in human hepatocellular cancer cellsRoberta Montalbano, Petra Waldegger, Karl Quint, et al.International Journal of Oncology|June 11, 2009
Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivoSamir Jabari, Matthias Meissnitzer, Karl Quint, et al.Oncology Letters|December 21, 2012
The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma modelsPietro DI Fazio, Roberta Montalbano, Karl Quint, et al.Mitochondrion|November 12, 2015
Deficiency of respiratory chain complex I in Hashimoto thyroiditisFranz A Zimmermann, Daniel Neureiter, René G Feichtinger, et al.International Journal of Molecular Sciences|June 2, 2021
Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell TherapyDominik Kiem, Michael Leisch, Daniel Neureiter, et al.International Journal of Molecular Sciences|September 10, 2021
A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case ReportMarkus Steiner, Franz J Gassner, Thomas Parigger, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 28, 2005
Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell linesDaniel Neureiter, Steffen Zopf, Arno Dimmler, et al.Expert Opinion on Drug Discovery|January 22, 2025
The importance of preclinical models for cholangiocarcinoma drug discoveryFelix J Krendl, Florian Primavesi, Rupert Oberhuber, et al.Journal of Gastrointestinal Oncology|May 19, 2025
Camrelizumab in combination with chemotherapy and targeted therapy improves the prognosis in patients with advanced biliary tract cancer: a single-center retrospective clinical studyYizhuo Zhang, Xiaolong Liu, Guixing Jiang, et al.Pageof 21